TNF and Cowden disease: Mercaptopurine is an effective immunomodulator and is frequently used in the maintenance remission of CD or in combination therapy with anti-TNF drugs to reduce the development of anti-drug antibodies, yet its ability to induce clinical remission is slow, rendering it unsuitable for rapid disease management (De Boer et al., 2018).